肠道菌群通过改变脑胰岛素敏感性与代谢调节神经行为
该研究在高脂饮食诱导肥胖(DIO)小鼠中评估行为与脑内胰岛素作用,发现DIO小鼠表现出焦虑和抑郁样行为,伴伏隔核与杏仁核胰岛素信号下降和炎症增加。口服甲硝唑或万古霉素可减轻炎症、改善脑胰岛素信号并减少焦虑抑郁表现,且效应可通过粪菌移植转移至无菌小鼠。
要点
- DIO小鼠出现焦虑抑郁样行为,伴伏隔核和杏仁核胰岛素信号下降、炎症增加
- 口服甲硝唑或万古霉素可改善脑胰岛素信号并减少焦虑抑郁表现
- 菌群效应与色氨酸、GABA、BDNF、氨基酸及多种酰基肉碱水平变化相关,并可通过粪菌移植转移
核心结论
- 肠道菌群变化可调控脑胰岛素信号与代谢物水平,进而改变神经行为。
研究设计与样本
- 研究采用高脂饮食诱导肥胖(DIO)小鼠,设置有无抗生素处理组,评估行为与脑内胰岛素作用。
- 通过粪菌移植将效应转移至无菌小鼠验证。
主要发现
- DIO小鼠表现出反映焦虑和抑郁增加的行为。
- DIO小鼠伏隔核和杏仁核胰岛素信号下降、炎症增加。
- 抗生素处理降低炎症、改善脑胰岛素信号并减少焦虑抑郁表现。
- 上述效应伴随色氨酸、GABA、BDNF、氨基酸及多种酰基肉碱水平变化。
临床怎么用
- 提示调节肠道菌群可能影响脑胰岛素信号与焦虑抑郁样行为,为相关机制研究提供依据。
- 甲硝唑或万古霉素的效应尚属动物实验观察,不能直接推导临床用药建议。
局限性
- 证据来自小鼠模型,尚不能直接外推至人类。
- 原文未报告样本量、具体效应量及统计阈值等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obesity and diabetes in humans are associated with increased rates of anxiety and depression. To understand the role of the gut microbiome and brain insulin resistance in these disorders, we evaluated behaviors and insulin action in brain of mice with diet-induced obesity (DIO) with and without antibiotic treatment. We find that DIO mice have behaviors reflective of increased anxiety and depression. This is associated with decreased insulin signaling and increased inflammation in in the nucleus accumbens and amygdala. Treatment with oral metronidazole or vancomycin decreases inflammation, improves insulin signaling in the brain and reduces signs of anxiety and depression. These effects are associated with changes in the levels of tryptophan, GABA, BDNF, amino acids, and multiple acylcarnitines, and are transferable to germ-free mice by fecal transplant. Thus, changes in gut microbiota can control brain insulin signaling and metabolite levels, and this leads to altered neurobehaviors.
引用
- Soto M, Herzog C, Pacheco JA, et al. Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism. Mol Psychiatry. 2018. PMID: 29910467. doi:10.1038/s41380-018-0086-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。